Spermotrend in the Treatment of Male Infertility

Assessment of the Efficacy of Dietary Supplement Spermotrend in the Treatment of Male Infertility

The purpose of this study is to determine whether the administration of the dietary supplement Spermotrend improves spermatogenesis parameters in subjects with male infertility unrelated to major testicular conditions. The duration of this double-blind placebo controlled phase 3 clinical trial will be 24 weeks. The estimated number of males with infertility to be recruited and randomized for the study is 86.

Inclusion Criteria:

• Male infertility unrelated to major testicular conditions
• Must have at least one altered seminal parameter.
• Signed informed consent

Exclusion Criteria:

• Hydrocele, varicocele, orchitis, epididymitis, irradiation or Chemotherapy.
• Previously treated and cured testicular condition.
• Non-transmissible chronic diseases
• Use of antioxidant agents within 6 months.
• Use of vitamins within 6 months.
• Use of anti-inflammatory drugs within 6 months.
• Use of hormones prescribed by an andrologist within 6 months
• Positive serology/HIV
• Leukocytospermia